Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
10:06am, Thursday, 30'th May 2024
Vertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
05:50am, Thursday, 30'th May 2024
Abbott and DexCom depend heavily on continuous glucose monitoring (CGM) device sales. Vertex is developing therapies that could cure type 1 diabetes.
Got $500? 3 Pharma Stocks to Buy and Hold Forever
10:15am, Sunday, 26'th May 2024
Vertex Pharmaceuticals is in the midst of a major diversification plan. Eli Lilly's medicines for diabetes and obesity are incredibly hot sellers.
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
09:45am, Sunday, 26'th May 2024
Vertex has achieved significant growth in recent years, but things have slowed lately. The company has many potential catalysts that could accelerate its growth rate.
2 Biotech Stocks to Buy in May
10:00am, Saturday, 25'th May 2024
Vertex is diversifying, moving beyond a therapeutic area it has thoroughly dominated. Regeneron has three important growth drivers and a pipeline that should produce more.
3 High-Flying Stocks That Could Soar Even More
06:47am, Saturday, 25'th May 2024
Eli Lilly is just getting started with its powerful obesity drug and a loaded pipeline. It's not too late to invest in scorching-hot Novo Nordisk.
New Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
04:28pm, Friday, 24'th May 2024
Cystic fibrosis treatment leader Vertex scored a breakout from a cup base this week, just a few weeks after an earnings beat.
Vertex to Participate in Upcoming June Investor Conferences
04:05pm, Wednesday, 22'nd May 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Dr. Reshma Kewalramani, Chief Executive Offic
Final Trades: Walmart, Vertex and the SMH
01:38pm, Wednesday, 22'nd May 2024
The Investment Committee gives you their top stocks to watch for the second half.
Vertex (VRTX) Outperforms Industry on Rapid Pipeline Progress
12:51pm, Tuesday, 21'st May 2024
While CF remains the main area of focus, Vertex (VRTX) has seen rapid success in its non-CF pipeline candidates' development in the past year.
Meridian Wealth Management LLC Has $323,000 Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
07:26am, Monday, 20'th May 2024
Meridian Wealth Management LLC lifted its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 4.1% during the fourth quarter, according to the company in its
Jennifer Schneider Elected to Vertex Board of Directors
10:30am, Wednesday, 15'th May 2024
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Jennifer Schneider, M.D., M.S., has been elected to its Board of Directors as an independent director.
Final Trades: Pfizer, Vertex, Freeport-McMoran and Qualcomm
01:55pm, Tuesday, 14'th May 2024
The Investment Committee give you their top stocks to watch for the second half.
Vertex Is Writing A New Playbook For Pharma R&D. And It's Working.
11:22am, Tuesday, 14'th May 2024
Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along the way
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
10:46am, Tuesday, 14'th May 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
